Well-Being and Performance of Nursery Pigs Subjected to Different Commercial Vaccines Against Porcine Circovirus Type 2, and .

Vaccination is a strategy in pig farming for the control of several pathogens, but commercial vaccines may have detrimental side effects. This study aimed to evaluate the effects of commercial vaccines on the control of porcine circovirus type 2 (PCV2), (Mhp), and (. ) and their potential side effects on welfare, behavior, acute inflammation biomarkers (C-reactive protein and haptoglobin), and the performance of piglets during the nursery phase.

Assessment of sow herd frequency of PCV-2 using placental umbilical cord serum and serology in 18 breeding farms in Brazil.

Porcine circovirus type 2 (PCV-2) is the agent of one of the most important diseases in the swine industry. Although it has been controlled through vaccination, viremic piglets at birth may represent a risk by reducing vaccination efficacy. Since there are few reports on the viremic status of pre-suckling piglets regarding PCV-2 infection, we assessed the PCV-2 frequency in sows housed in 18 breeding farms with no history of clinical PCVAD in Brazil, using placental umbilical cord serum (PUCS).

Impact of increasing weaning age on pig performance and belly nosing prevalence in a commercial multisite production system.

The effects of increasing weaning age in a commercial production system on nursery and finishing performance were evaluated. A total of 1,176 pigs (PIC 337 × Camborough) were used in a 136-d growth trial with 14 and 10 replications/weaning age on the nursery and finishing phases, respectively. Treatments included weaning litters at 19, 22, 25, or 28 d of age.